Inspired by recent findings on the conserved role of IGF2BP1 in promoting cancer cell cycle progression by promoting E2F-driven gene expression in cancer (Müller et al., 2020), we aim at evaluating strategies for identifying conserved effector pathways and potentially targetable effectors of IGF2BP1 in this study. This evidence concerns the gene IGF2BP1 and cancer.